Anticoagulants.
Anticoagulants are the class where onset, monitoring and reversal are all consequences of one design choice: whether the drug blocks clotting factors that already exist or prevents new ones being made. Every comparison question in this area reduces to that.
The mechanism in one sentence
Anticoagulants interrupt the clotting cascade at different points, and where a drug acts determines how fast it works, how it is monitored and how it is reversed.
Heparin works on factors already circulating. It potentiates antithrombin, which then inactivates thrombin and factor Xa, so the effect is immediate and disappears as the drug is cleared. Warfarin works on production instead: it blocks vitamin K epoxide reductase, so the liver cannot carboxylate factors II, VII, IX and X, and nothing changes until the factors already in circulation are used up. That is why warfarin takes days to work and why its effect persists after stopping. The direct oral anticoagulants take the third route and bind a single target directly, either thrombin or factor Xa, giving rapid onset without routine monitoring.
Members of the class
| Drug | What sets it apart |
|---|---|
| Unfractionated heparin | Immediate, monitored by aPTT, reversed by protamine, short half-life. |
| Low molecular weight heparin | More predictable, weight-based dosing, renally cleared, anti-Xa monitoring only when needed. |
| Warfarin | Slow onset, INR-monitored, reversed with vitamin K, extensive interactions. |
| Apixaban and rivaroxaban | Direct factor Xa inhibitors, oral, fixed dose, reversed with andexanet alfa where available. |
| Dabigatran | Direct thrombin inhibitor, reversed with idarucizumab. |
What the class is used for
- Treatment and prevention of venous thromboembolism
- Stroke prevention in atrial fibrillation
- Prophylaxis around surgery and during immobility
- Mechanical heart valves, where warfarin remains the required agent
Side effects, derived from the mechanism
Each entry below follows from the mechanism above rather than being a separate fact. Read the middle column as the answer to the question, why would that happen.
| Effect | Why it follows |
|---|---|
| Bleeding | The therapeutic effect taken too far. Risk tracks the intensity of anticoagulation, which is why monitoring exists for the agents that need it. |
| Heparin-induced thrombocytopenia | An immune reaction to the heparin-platelet factor 4 complex. Counter-intuitively it causes thrombosis rather than bleeding, and it requires stopping all heparin rather than reducing the dose. |
| Warfarin skin necrosis | Early in treatment, protein C falls faster than the clotting factors do, producing a brief prothrombotic window. This is why heparin bridges the start of warfarin therapy. |
| Accumulation in renal impairment | Low molecular weight heparins and the DOACs are renally cleared to varying degrees, so falling renal function raises bleeding risk. |
Contraindications and cautions
- Active major bleeding
- Warfarin in pregnancy, because it is teratogenic; heparins do not cross the placenta
- DOACs in mechanical heart valves and in severe renal impairment, depending on the agent
The part you cannot derive
Warfarin has a narrow therapeutic index, is highly protein bound and is metabolised by CYP2C9, and its target is a vitamin obtained from food. That combination is why its interaction list is longer than almost any other drug: diet, antibiotics, antifungals and enzyme inducers all move the INR.
Exam traps
Heparin bridging is about protein C, not impatience
The overlap exists because warfarin is briefly prothrombotic at the start, not merely because it is slow.
Vitamin K reverses warfarin, protamine reverses heparin
Swapping these is the most common error in the topic. Match the antidote to the mechanism: vitamin K restores factor synthesis, protamine binds heparin directly.
HIT causes clots
A falling platelet count on heparin suggests thrombosis risk, not bleeding risk, which is the opposite of what the word thrombocytopenia suggests.
Members of this class that get confused
Within a class, the members differ on one property at a time, and that property is what exam questions are usually built on. These pairs split cleanly.
- Heparin vs Warfarin — Heparin acts on clotting factors that already exist, so it works immediately, is monitored by aPTT and is reversed with protamine.
- Warfarin vs DOACs — Warfarin blocks the synthesis of several clotting factors at once, which is why it needs INR monitoring; a DOAC binds one activated factor directly, which makes its effect predictable enough to give at a fixed dose.
- Unfractionated heparin vs Enoxaparin — Enoxaparin is heparin cut into shorter chains, and chain length is the whole comparison.
Test yourself on this
Reading a mechanism and being able to retrieve it under time are different skills, and only the second one is examined. These are free and need no account.
- Cardiovascular pharmacology practice questions — 10 questions with explanations
- Warfarin counselling and the INR
- Heparin vs enoxaparin
- CYP450 inducers and inhibitors
- Creatinine clearance calculator (Cockcroft-Gault) — free calculator with a worked example
- Ideal and adjusted body weight calculator — free calculator with a worked example
Common questions
What is the difference between heparin and warfarin?
Heparin potentiates antithrombin to inactivate clotting factors that already exist, so it works immediately, is monitored by aPTT and is reversed with protamine. Warfarin blocks the synthesis of new clotting factors, so it takes days to work, is monitored by INR and is reversed with vitamin K.
Why does warfarin take days to work?
It stops new clotting factors being made but does nothing to the ones already circulating. The anticoagulant effect only appears as those existing factors are consumed, which depends on their individual half-lives.
Why do DOACs not need routine monitoring?
They bind a single clotting factor directly and have predictable pharmacokinetics at a fixed dose, so the relationship between dose and effect is consistent enough not to require an INR-style measurement.
Other drug classes
Beta blockers · ACE inhibitors · Statins · Diuretics · Opioids · Benzodiazepines · All drug classes
Study aid only. This page is written for learning and examination practice. It is not medical advice, not clinical decision support, and must never be used to make a decision about a real patient. Always verify against your local formulary, the product literature and a qualified pharmacist. See our medical disclaimer.
Understanding it once is easy. Keeping it is the work.
PharmBit brings anticoagulants back on the schedule that makes them stick. Free to download.
Free to download. Annual Pro: 7-day trial for eligible new subscribers.